BPR groups its 22 biocidal product types into four broad areas, each requiring separate active substance approval and product authorisation for the relevant product type. Establishing which product types apply to a formulation is one of the first steps in scoping a BPR position.
Before a biocidal product can be placed on the market, every active substance it contains must first be approved for the relevant product type, either at EU level or under the GB BPR run by HSE. Product authorisation for the finished product then follows, through whichever route fits the product and the markets it will be sold into — national authorisation with mutual recognition, Union authorisation, or simplified authorisation for lower-risk products.
For products containing an active substance still going through the EU or GB review programme, transitional arrangements under Article 89 can allow continued supply under national rules while that review is completed — a position that needs to be tracked and evidenced, not assumed.
The same biocidal product can carry different duties depending on whether you supply the active substance, hold the product authorisation, distribute the finished product, or supply an article treated with it. We help establish your role for each product and what it means in practice.
Get specialist regulatory and material assurance support across the UK, EU, industry and defence sectors — REACH, CLP, BPR, DSEAR and the evidence to back it up.
Product Stewardship Ltd provides specialist regulatory support, material assurance and compliance training for organisations operating across the UK, EU, industry and defence sectors.
Speak to us about REACH, CLP, defence material assurance, training or workplace compliance.